A dedicated manufacturing facility, being built as an extension to Astra Polymers plant, will produce Customer Specific Blends (CSB’s) using Ciba Specialty Chemical’s proprietary form-giving technology. The manufacturing facility will be situated in Dammam, Kingdom of Saudi Arabia.
Astra Polymers, a well-established supplier of the polymer manufacturing and processing industry in the Middle East and Far East Asia, will be responsible for all manufacturing processes while Ciba Specialty Chemicals, market leader in stabilization and effects chemistry, will be responsible for the technology, technical support and sale of the Customer Specific Blends (CBS’s). Astra Polymers and Ciba will work closely with regional customers to develop tailored blends that will satisfy both their stabilization and additive handling requirements.
The regional supply of these Customer Specific Blends (CSB’s) offers advanced additive systems to the Middle East polymer industry that will help to increase productivity gains in the area. Customer Specific Blends (CSB’s) are multi-component packages that combine stabilizers and other additives used by polymer manufacturers into single, easy-to-handle blends. They simplify the incorporation process and improve worker hygiene and resin quality.
Germano Peverelli, Regional Vice President of Polymer Additives outlined the benefits of the cooperation: “The alliance will further strengthen Ciba’s presence in the Middle East. With the introduction and local production of Customer Specific Blends, Ciba will be able to better support the polymer industry in this strategically important and fast growing market”.
Mohammad N. Al-Utaibi, Managing Director of Astra Polymers, stated: “Ciba Specialty Chemicals is the strategic choice for Astra Polymers. With the added technical and marketing expertise, the company will be in an excellent position to meet the growing demands of the polymer industry in the Middle East.
Thursday, September 11- 2003 @ 13:25 UAE local time (GMT+4) Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of Mediaquest FZ LLC.